This article has Open Peer Review reports available.
Toxoplasma gondii pseudocyst in a transbronchial biopsy: a case report
© The Author(s). 2016
Received: 5 February 2016
Accepted: 12 August 2016
Published: 22 September 2016
We herein present a case in which a Toxoplasma cyst was found in a transbronchial biopsy specimen from an immunocompetent patient with negative serology for the parasite.
An 18-year-old Brazilian man presented with a 1-week history of dyspnea and fever and was diagnosed with right lower lobe pneumonia. He began inpatient treatment with intravenous antibiotics. During treatment, a bronchoscopy with bronchoalveolar lavage and transbronchial biopsy was performed. Anatomopathological examination of the transbronchial biopsy showed a small fragment of lung parenchyma with discrete septal thickening and a rounded structure, suggestive of a pseudocyst containing Toxoplasma gondii bradyzoites. However, serological tests were negative for immunoglobulin G and immunoglobulin M.
Bronchoscopy is a minimally invasive, effective diagnostic and therapeutic method. Despite the fact that the Toxoplasma pseudocyst in the present case was not the cause of the patient’s comorbidities, bronchoscopy with transbronchial biopsy allowed for an incidental diagnosis of a Toxoplasma pseudocyst with minimal invasiveness.
Toxoplasmosis is a disease that affects mammals and birds worldwide and is caused by the parasite Toxoplasma gondii. It can take several forms in humans, ranging from oligosymptomatic to severe. Symptoms mainly involve the heart, liver, lungs, eyes, and brain, and the most serious cases are diagnosed in patients with impaired immunity. We herein present a case in which a single Toxoplasma pseudocyst was found in a transbronchial biopsy specimen from an immunocompetent patient with negative serology for the parasite.
An 18-year-old Brazilian man developed dyspnea and fever of one week’s duration and was then diagnosed with right lower lobe pneumonia. Before this incident, he had not experienced any medical complications, lived in full sanitary conditions, denied previous symptoms related to disease, did not have any pets, and denied eating raw meat. He then began hospital inpatient treatment with intravenous antibiotics, and third-generation cephalosporin (Ceftriaxone) and a macrolide (Clarithromycin) were prescribed for 8 days. Laboratory tests from the patient’s admittance showed mild anemia with a hemoglobin (Hb) level of 11.7 g/dL, with normal mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH). Other biochemical results were as follows: creatinine 0.9 mg/dL, urea 32 mg/dL, total bilirubin 0.2 mg/dL, glucose 90 mg/dL, sodium 134 mEq/L, potassium 3.7 mEq/L, and C-reactive protein 138.2 mg/L. Leucocytes levels were a little low, with 2700 cells/μL. Blood and urine cultures were negative for infection and serological tests for human immunodeficiency virus (HIV), hepatitis B and C, and syphilis were all negative.
Our patient was followed up on an outpatient basis for 2 years without any signs of recurrence of lung infections or other comorbidities. Serology for toxoplasmosis were repeated and remained negative.
Toxoplasma gondii is a protozoan  whose obligate intracellular life cycle of infection is divided into different stages: tachyzoite; merozoite, which gives rise to gametes and eggs; and zygote, which gives rise to the oocyst. In the external environment, the oocyst undergoes meiotic division and forms two sporocysts, each with four sporozoites that are highly resistant to disinfectants and can last up to 5 years in the environment [2, 3]. If a human is infected, the intestinal oocysts become numerous tachyzoites through asexual reproduction. The human being is considered an intermediate host because final sexual maturation occurs only in the intestines of dogs .
Tachyzoites cause acute infection in which some parasites become numerous cysts containing bradyzoites, as in the present case. This occurs after the immune response that controls the infection is activated; a positive result on serological tests is then obtained .
During chronic infection, bradyzoites slowly multiply within their cysts, and multiplication may even stop. This multiplication occurs within the cytoplasmic vacuoles, whose membranes become the cyst capsule. The capsule, composed of glycoproteins, isolates bradyzoites from the immune mechanisms of the host. Thus, the cysts persist intact for months to years and can result in negative serological tests.
The primary T. gondii infection pathway involves fecal–oral transmission or eating meat from other intermediate hosts, such as pigs, poultry, sheep, and cattle. T. gondii infection can also be transmitted to the fetus through the placenta. Eosinophilia is generally an atypical finding during infection with the protozoan. Clinical manifestations are complicated and atypical, and most infections are latent or acute; differential diagnosis is mainly based on direct detection of Toxoplasma tachyzoites or serological techniques .
Immunocompetent patients with acute T. gondii infection are usually asymptomatic. However, up to 10 % of cases can have nonspecific and self-limited clinical manifestations that rarely require treatment. Lymphadenopathy (bilateral, symmetrical, and hardened) is one of the most common clinical manifestations. Pulmonary manifestations in immunocompetent patients are rare and can appear as dry cough, fever, nonspecific symptoms (such as myalgia, weakness, and rash) and radiological findings that can also correspond to the findings of atypical pneumonia (diffuse interstitial pulmonary infiltrates) .
The unprecedented finding in the present case was a pseudocyst with bradyzoites in the lung parenchyma in a patient with negative serology for the parasite. We found no descriptions of similar cases in the literature, thus making our experience in this case noteworthy. This finding was likely associated with direct infection by inhalation of a cyst that was not activated in the lung environment. More remarkably, we were able to extract this cyst from the transbronchial biopsy specimen. Diagnosis of acute lung infection with a protozoan at the time of biopsy is truly akin to finding a needle in a haystack.
T. gondii infection has various clinical presentations and multiple forms. Humans are intermediate hosts of T. gondii because we do not provide a favorable environment for the parasite to complete its sexual cycle. Bronchoscopy is a minimally invasive, effective diagnostic and therapeutic method. In this case, despite the fact that the Toxoplasma cyst was not the cause of our patient’s comorbidities, bronchoscopy with transbronchial biopsy allowed for an incidental diagnosis of a Toxoplasma pseudocyst with minimal invasiveness.
Availability of data and supporting materials section
TRN and CCC performed the transbronchial biopsy. TRN, CCC, and APN performed the clinical evaluation. TRN, AAN, and PCU analyzed all examination findings and the medical history of the patient regarding this pathology. All authors read and approved the final manuscript.
Caio César Inaco Cirino, MD is a thoracic surgeon at Americo Brasiliense State Hospital, University of São Paulo, Brazil.
André Peluso Nogueira, MD is an infectologist at Americo Brasiliense State Hospital, University of São Paulo, Brazil.
André Amate Neto, MD is a thoracic surgeon at Americo Brasiliense State Hospital, University of São Paulo, Brazil.
Patrícia Cristina Urbano is a nurse at Americo Brasiliense State Hospital, University of São Paulo, Brazil.
Tales Rubens de Nadai, MD, PhD is a thoracic surgeon in the Department of Surgery and Anatomy, Ribeirão Preto School of Medicine, University of São Paulo, Brazil and Americo Brasiliense State Hospital, University of São Paulo, Brazil.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Black MW, Boothroyd JC. Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev. 2000;64:607–23.View ArticlePubMedPubMed CentralGoogle Scholar
- Furtado JM, et al. Toxoplasmosis: a global threat. J Glob Infect Dis. 2011;3:281–4.View ArticlePubMedPubMed CentralGoogle Scholar
- De Salvador-Guillouet F, et al. Severe pneumonia during primary infection with an atypical strain of Toxoplasma gondii in an immunocompetent young man. J Infect. 2006;53:47–50.View ArticleGoogle Scholar
- Leal FE, et al. Toxoplasma gondii pneumonia in immunocompetent subjects: case report and review. Clin Infect Dis. 2007;44:62–6.View ArticleGoogle Scholar
- Edvinsson B, et al. Toxoplasmosis in immunocompromized patients. Scand J Infect Dis. 2009;41:368–71.View ArticlePubMedGoogle Scholar
- Lu N, et al. Toxoplasmosis complicating lung cancer: a case report. Int Med Case Rep J. 2015;8:37–40.View ArticlePubMedPubMed CentralGoogle Scholar
- Villard O, et al. Serological diagnosis of Toxoplasma gondii infection: recommendations from French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis. 2016;84(1):22–33.View ArticlePubMedGoogle Scholar